Universal Ibogaine Inc. (IBOGF)

OTCMKTS · Delayed Price · Currency is USD
0.0193
+0.0027 (16.51%)
Jun 27, 2025, 1:19 PM EDT
157.87%
Market Cap 5.65M
Revenue (ttm) 1.49M
Net Income (ttm) -1.07M
Shares Out n/a
EPS (ttm) -0.00
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 15,000
Average Volume 127,936
Open 0.0206
Previous Close 0.0166
Day's Range 0.0193 - 0.0206
52-Week Range 0.0013 - 0.1000
Beta 6.50
RSI 50.74
Earnings Date Jun 27, 2025

About Universal Ibogaine

Universal Ibogaine Inc., a life sciences company, develops, acquires, and operates addiction treatment clinics in Canada. The company also undertakes planned clinical trial for research into the use of ibogaine for addiction treatment. Universal Ibogaine Inc. is headquartered in Calgary, Canada. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Nicholas Karos
Country Canada
Stock Exchange OTCMKTS
Ticker Symbol IBOGF
Full Company Profile

Financial Performance

In 2024, Universal Ibogaine's revenue was 2.33 million, an increase of 126.32% compared to the previous year's 1.03 million. Losses were -2.05 million, -14.17% less than in 2023.

Financial numbers in CAD Financial Statements

News

Universal Ibogaine Advises of Debt Settlement Agreement and Update on Status of Cease Trade Order

Calgary, AB – TheNewswire - April 3, 2025 – Universal Ibogaine Inc. ( TSXV:IBO) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addiction ...

3 months ago - TheNewswire

Universal Ibogaine Provides Update on Status of Current Cease Trade Order

Calgary, AB – February 5, 2025 – TheNewswire - Universal Ibogaine Inc. ( TSXV:IBO) (“ UI ” or the “ Company ”), a life sciences company with a mission to deliver medicalized ibogaine-centered addicti...

5 months ago - TheNewswire

Universal Ibogaine Co-Founder Dr Alberto Sola to Present at upcoming Research to Reality Conference

CALGARY, AB , May 13, 2022 /PRNewswire/ - Universal Ibogaine Inc. (TSXV: IBO) (OTCQB: IBOGF) (FSE: JC4) ("UI" or the "Company") a life sciences company with a mission to transform addiction treatment ...

3 years ago - PRNewsWire

UNIVERSAL IBOGAINE RETAINS SHAYNE NYQUVEST AS CAPITAL MARKETS ADVISOR

CALGARY, AB , April 29, 2022 /PRNewswire/ - Universal Ibogaine Inc. (TSXV: IBO) (OTCQB: IBOGF) (FSE: JC4) ("UI" or the "Company") a life sciences company with a mission to develop and deliver medicali...

3 years ago - PRNewsWire

UNIVERSAL IBOGAINE PROVIDES UPDATE ON KELBURN RECOVERY CENTER OPERATIONS

CALGARY, AB , April 7, 2022 /PRNewswire/ - Universal Ibogaine Inc. (TSXV: IBO) ("UI" or the "Company") a life sciences company with a mission to develop and deliver medicalized ibogaine-centered addic...

3 years ago - PRNewsWire

Universal Ibogaine Announces Frankfurt Stock Exchange Listing

CALGARY, AB , April 6, 2022 /PRNewswire/ - Universal Ibogaine Inc. (TSXV: IBO) (OTCQB: IBOGF) (FSE: JC4) ("UI" or the "Company") a life sciences company with a mission to transform the world of addict...

3 years ago - PRNewsWire